Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
HKD 9.13
(0.0%)
HKD 9.13
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.59 Billion CNY | 7.5% |
| 2022 | 1.48 Billion CNY | 14.45% |
| 2021 | 1.29 Billion CNY | 25.81% |
| 2020 | 1.03 Billion CNY | 19.82% |
| 2019 | 860.69 Million CNY | 15.38% |
| 2018 | 745.97 Million CNY | 11.93% |
| 2017 | 666.43 Million CNY | 60.43% |
| 2016 | 415.4 Million CNY | 20.87% |
| 2015 | 343.67 Million CNY | 15.99% |
| 2014 | 296.29 Million CNY | 30.89% |
| 2013 | 226.36 Million CNY | 32.52% |
| 2012 | 170.81 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | 409.17 Million CNY | 5.2% |
| 2023 FY | 1.59 Billion CNY | 7.5% |
| 2023 Q4 | 409.17 Million CNY | 0.0% |
| 2023 Q1 | 388.96 Million CNY | 4.2% |
| 2023 Q2 | 388.96 Million CNY | 0.0% |
| 2022 Q1 | 369.15 Million CNY | 7.05% |
| 2022 FY | 1.48 Billion CNY | 14.45% |
| 2022 Q4 | 373.29 Million CNY | 0.0% |
| 2022 Q3 | 373.29 Million CNY | 1.12% |
| 2022 Q2 | 369.15 Million CNY | -0.0% |
| 2021 Q1 | 303.86 Million CNY | 16.01% |
| 2021 Q2 | 303.86 Million CNY | 0.0% |
| 2021 FY | 1.29 Billion CNY | 25.81% |
| 2021 Q4 | 344.84 Million CNY | 0.0% |
| 2021 Q3 | 344.84 Million CNY | 13.49% |
| 2020 Q4 | 261.93 Million CNY | -0.0% |
| 2020 Q2 | 232.57 Million CNY | 0.0% |
| 2020 FY | 1.03 Billion CNY | 19.82% |
| 2020 Q1 | 232.57 Million CNY | -3.45% |
| 2020 Q3 | 261.93 Million CNY | 12.62% |
| 2019 Q4 | 240.89 Million CNY | 0.0% |
| 2019 Q3 | 240.89 Million CNY | 27.15% |
| 2019 Q2 | 189.45 Million CNY | -0.0% |
| 2019 Q1 | 189.45 Million CNY | -2.64% |
| 2019 FY | 860.69 Million CNY | 15.38% |
| 2018 Q4 | 194.59 Million CNY | 0.0% |
| 2018 Q3 | 194.59 Million CNY | 9.09% |
| 2018 Q2 | 178.38 Million CNY | -0.0% |
| 2018 Q1 | 178.38 Million CNY | -6.92% |
| 2018 FY | 745.97 Million CNY | 11.93% |
| 2017 FY | 666.43 Million CNY | 60.43% |
| 2017 Q4 | 191.64 Million CNY | 0.0% |
| 2017 Q3 | 191.64 Million CNY | 35.38% |
| 2017 Q2 | 141.56 Million CNY | -0.0% |
| 2017 Q1 | 141.56 Million CNY | 25.43% |
| 2016 Q4 | 112.86 Million CNY | 0.0% |
| 2016 FY | 415.4 Million CNY | 20.87% |
| 2016 Q3 | 112.86 Million CNY | 19.0% |
| 2016 Q2 | 94.84 Million CNY | -0.0% |
| 2016 Q1 | 94.84 Million CNY | 3.69% |
| 2015 Q1 | 80.37 Million CNY | 1.29% |
| 2015 FY | 343.67 Million CNY | 15.99% |
| 2015 Q2 | 80.37 Million CNY | 0.0% |
| 2015 Q3 | 91.46 Million CNY | 13.8% |
| 2015 Q4 | 91.46 Million CNY | 0.0% |
| 2014 Q4 | 79.35 Million CNY | 0.0% |
| 2014 Q2 | 68.79 Million CNY | 0.0% |
| 2014 FY | 296.29 Million CNY | 30.89% |
| 2014 Q1 | 68.79 Million CNY | -7.12% |
| 2014 Q3 | 79.35 Million CNY | 15.34% |
| 2013 FY | 226.36 Million CNY | 32.52% |
| 2013 Q4 | 74.07 Million CNY | 0.0% |
| 2012 FY | 170.81 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 554.58 Million HKD | -187.833% |
| UMP Healthcare Holdings Limited | 748.48 Million HKD | -113.265% |
| Human Health Holdings Limited | 590.81 Million HKD | -170.178% |
| EuroEyes International Eye Clinic Limited | 714.28 Million HKD | -123.476% |
| Kato (Hong Kong) Holdings Limited | 271.33 Million HKD | -488.303% |
| Bamboos Health Care Holdings Limited | 94.78 Million HKD | -1584.055% |
| Beijing Health (Holdings) Limited | 140.34 Million HKD | -1037.379% |
| C-MER Eye Care Holdings Limited | 1.92 Billion HKD | 17.032% |
| Town Health International Medical Group Limited | 1.83 Billion HKD | 12.917% |
| Medicskin Holdings Limited | 49.13 Million HKD | -3148.734% |
| Hang Chi Holdings Limited | 211.21 Million HKD | -655.757% |